Spinal cord injury sequelae alter drug pharmacokinetics: an overview
Authors:
- 31 May 2011
- journal article
- review article
- Published by Springer Nature in Spinal Cord
- Vol. 49 (9) , 955-960
Abstract
Study design: Objectives: Methods: Results: Conclusion:Keywords
This publication has 50 references indexed in Scilit:
- Recovery of airway protective behaviors after spinal cord injuryRespiratory Physiology & Neurobiology, 2009
- Dantrolene can reduce secondary damage after spinal cord injuryEuropean Spine Journal, 2009
- Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injuryNeurochemistry International, 2008
- Mechanisms of Disease: involvement of the urothelium in bladder dysfunctionNature Reviews Endocrinology, 2007
- Phase 2 trial of sustained-release fampridine in chronic spinal cord injurySpinal Cord, 2006
- Metoclopramide Increases the Bioavailability of Dantrolene in Spinal Cord InjuryThe Journal of Clinical Pharmacology, 1996
- Decreased Systemic Clearance of Lorazepam in Humans With Spinal Cord InjuryThe Journal of Clinical Pharmacology, 1991
- Amikacin serum protein binding in spinal cord injuryLife Sciences, 1991
- Mechanisms underlying the recovery of urinary bladder function following spinal cord injuryJournal of the Autonomic Nervous System, 1990
- Clinical Pharmacokinetics in Patients with Spinal Cord InjuriesClinical Pharmacokinetics, 1989